On October 7, 2025, Cellectar Biosciences, Inc. entered into agreements allowing holders to exercise existing warrants for 1,048,094 shares at $5.25 each, raising about $5.8 million. They reported an estimated cash balance of $12.6 million as of September 30, 2025.